Quarter Ended Sep 30, 2020
SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by developing innovative therapies. The SCYNEXIS team has extensive experience in the life sciences industry, discovering and developing more than 30 innovative medicines over a broad range of therapeutic areas.
LifeSci Advisors
Irina Koffler
T: 646-970-4681
ikoffler@lifesciadvisors.com
LifeSci Communications
Gloria Gasaatura
T: 646-970-4688
ggasaatura@lifescicomms.com
American Stock Transfer & Trust Company, LLC
10150 Mallard Creek Road
Suite 307
Charlotte, NC 28262
T: 800-937-5449